Of the 240 cos presenting only three from Australia are attending , Solbec , Alchemia and Novogen . Rodman and Renshaw look to be the top investment bank for biotechs in the USA . Being held at the Waldorf Astoria in New York . Includes company presentations , breakout sessions , Q & A and one-on-one meetings . It would be nice if Steve Carter has some more trial results to reveal . On Oct 26-28 . Solbec is on first day in the morning . I would have thought 8.40 was a bit early , but it is right after Dendreon and followed by CancerVax , both heavy hitters in the cancer vaccine race . An interesting co presenting at the same time is Xenova , licensed out an autoimmune drug , OX-40 fusion protein in pre clinicals to Genentech for $63m , among others .
PlacementTracker Publishes 2003 PIPE League Tables
447 Million in Banking Fees Earned in 2003 Represents an 80% Increase over 2002
San Diego - January 27, 2004 - Sagient Research Systems (OTCBB: PCSR), a leading
publisher of independent research for the financial services and institutional investment
communities, today announced that Rodman & Renshaw, Inc. ranked #1 in the PIPE
market in 2003 for both total dollars raised and number of transactions. Published
by Sagient Research's PlacementTracker service, the 2003 PIPE Market League Tables
ranked Lehman Brothers, Inc. (NYSE: LEH) and Roth Capital Partners, LLC as #2 and
#3 respectively by total dollars raised. Roth Capital Partners, LLC and SG Cowen
Securities Corporation ranked #2 and #3 respectively in number of PIPE transactions.
PlacementTracker, a flagship product of Sagient Research Systems, is well recognized as
the leading provider of research, data, and analytics covering the PIPE market.
PlacementTracker also reported that investment-banking firms reported a record amount
of investment banking and advisory fees from PIPE transactions in 2003. The annual fee
total of $447 million in 2003 was up from $248 million reported in 2002. This 80% one
year increase set a new single year record for investment banking and advisory fees in the
PIPE market.
PlacementTracker's dynamically updating League Tables for 2003 and 2004 are now
available online at: www.placementtracker.com.
The 2003 PIPE Market League Table By Dollar Amount Raised:
Placement Agent Transaction Count Total Amount Raised
Rodman & Renshaw, Inc. 31 $408,944,433.00
Lehman Brothers, Inc. (NYSE: LEH) 6 $362,344,031.00
Roth Capital Partners, LLC 24 $311,240,541.00
Credit Suisse First Boston Corp. 4 $272,439,900.00
Banc of America Securities LLC (NYSE: BAC) 6 $227,683,522.00
Jefferies & Co. Inc. (NYSE: JEF) 7 $217,849,996.00
SG Cowen Securities Corporation 16 $212,204,338.00
C.E. Unterberg, Towbin 13 $205,600,246.00
Friedman, Billings, Ramsey & Co. (NYSE: FBR) 1 $196,020,000.00
J.P. Morgan Chase & Co. (NYSE: JPM) 4 $172,100,603.00
Fleet Securities, Inc. (NYSE: FBF) 2 $156,000,000.00
UBS Investment Bank (NYSE: UBS) 6 $143,869,380.00
RBC Capital Markets, Inc. 4 $135,363,420.00
A.G. Edwards & Sons, Inc. (NYSE: AGE) 8 $134,816,209.00
Houlihan, Lokey, Howard, & Zukin Capital 5 $134,786,289.00
Raymond James & Associates Inc. 3 $130,800,149.00
Bear, Stearns & Co. Inc. 1 $126,000,000.00
Leerink Swann & Co. 5 $125,273,602.00
Merriman Curhan Ford & Company (AMEX: MEM) 11 $123,187,356.00
Harris Nesbitt Gerard 6 $119,578,348.00
Data presented excludes all Equity Line of Credit transactions and all PIPE transactions conducted by non-U.S. domiciled
issuers. For transactions where multiple firms are reported as co-placement agent, each placement agent is given full credit
for the total amount raised. Data is as reported as of 1/26/04.
SBP
solbec pharmaceuticals limited
Of the 240 cos presenting only three from Australia are...
Add to My Watchlist
What is My Watchlist?